Corrections: Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study (The Lancet Infectious Diseases (2018) (S147330991830121X) (10.1016/S1473-3099(18)30121-X));Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study

The Lancet Infectious Diseases

Volumn 18, Issue 6, 2018, Pages 684-695

  Okokhere, Peter ^a,b   Colubri, Andres ^c,d,e   Azubike, Chukwuemeka ^a   Iruolagbe, Christopher ^a   Osazuwa, Omoregie ^a   Tabrizi, Shervin ^d   Chin, Elizabeth ^c,g,h   Asad, Sara ^d   Ediale, Ehi ⁱ   Rafiu, Mojeed ^a   Adomeh, Donatus ^a   Odia, Ikponmwosa ^a   Atafo, Rebecca ^a   Aire, Chris ^a   Okogbenin, Sylvanus ^a   Pahlman, Meike ^j,k   Becker Ziaja, Beate ^j,k   Asogun, Danny ^a   Fradet, Terrence ^l   Fry, Ben ^l   Schaffner, Stephen F ^c,d,f   Happi, Christian ^m   Akpede, George ^a,b   Günther, Stephan ^j,k   Sabeti, Pardis C ^c,d,e,f   more..

^a IRRUA SPECIALIST TEACHING HOSPITAL   (Nigeria)

^b AMBROSE ALLI UNIVERSITY   (Nigeria)

^c HARVARD UNIVERSITY   (United States)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h Department of Bioinformatics ^*  (United States)

ⁱ MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^j BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^k German Centre for Infection Research   (Germany)

^l Fathom Information Design   (United States)

^m REDEEMER S UNIVERSITY   (Nigeria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATININE; POTASSIUM;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BRAIN DISEASE; CASE FATALITY RATE; CLINICAL LABORATORY; COHORT ANALYSIS; CONTROLLED STUDY; COUGHING; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIARRHEA; DISORIENTATION; ENCEPHALITIS; FEMALE; FOLLOW UP; HEADACHE; HEALTH CARE FACILITY; HEMATURIA; HUMAN; JAUNDICE; KIDNEY INJURY; LASSA FEVER; LASSA VIRUS; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MORTALITY; MORTALITY RISK; NECK SWELLING; NIGERIA; OBSERVATIONAL STUDY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SORE THROAT; THORAX PAIN; TREATMENT OUTCOME; TREMOR; UREA NITROGEN BLOOD LEVEL; VOMITING; WEAKNESS; EPIDEMIOLOGY; MULTIVARIATE ANALYSIS; PATHOLOGY; STATISTICAL MODEL;

ADULT; COHORT STUDIES; FEMALE; HUMANS; LASSA FEVER; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; NIGERIA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 85042849394     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(18)30208-1     Document Type: Erratum

References (30)

1. Grant, DS, Khan, H, Schieffelin, J, Bausch, DG, Chapter 4-Lassa fever. Emerging infectious diseases. 2014, Academic Press, Amsterdam, 37–59.
2. Frame, JD, Baldwin, JM Jr, Gocke, DJ, Troup, JM, Lassa fever, a new virus disease of man from west Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg 19 (1970), 670–676.
3. Safronetz, D, Sogoba, N, Diawara, SI, et al. Annual incidence of Lassa virus infection in southern Mali. Am J Trop Med and Hyg 96 (2017), 944–946.
4. Shaffer, JG, Grant, DS, Schieffelin, JS, et al. Lassa fever in post-conflict Sierra Leone. PLoS Negl Trop Dis, 8, 2014, e2748.
5. McCormick, JB, King, IJ, Webb, PA, et al. Lassa fever: effective therapy with ribavirin. N Engl J Med 314 (1986), 20–26.
6. Mire, CE, Cross, RW, Geisbert, JB, et al. Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever. Nat Med, 23, 2017, 1146.
7. Robinson, JE, Hastie, KM, Cross, RW, et al. Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits. Nat Commun, 7, 2016, 11544.
8. Zapata, JC, Salvato, MS, Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man. Future Virol 10 (2015), 233–256.
9. McCormick, JB, Fisher-Hoch, SP, Lassa fever. Curr Top Microbiol Immunol, 262, 2002, 24.
10. Yun, NE, Walker, DH, Pathogenesis of Lassa fever. Viruses, 4, 2012, 2031.
11. McCormick, JB, King, IJ, Webb, PA, et al. A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis 155 (1987), 445–455.
12. Zwizwai, R, Infection disease surveillance update. Lancet Infect Dis, 16, 2016, 157.
13. Andersen Kristian, G, Shapiro, BJ, Matranga Christian, B, et al. Clinical sequencing uncovers origins and evolution of Lassa virus. Cell 162 (2015), 738–750.
14. Bente, DA, Forrester, NL, Watts, DM, McAuley, AJ, Whitehouse, CA, Bray, M, Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res 100 (2013), 159–189.
15. Bird, BH, Khristova, ML, Rollin, PE, Ksiazek, TG, Nichol, ST, Complete genome analysis of 33 ecologically and biologically diverse Rift Valley fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry. J Virol 81 (2007), 2805–2816.
16. Asogun, DA, Adomeh, DI, Ehimuan, J, et al. Molecular diagnostics for Lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation. PLoS Negl Trop Dis, 6, 2012, e1839.
17. Okokhere, PO, Bankole, IA, Akpede, GO, Central nervous system manifestations of Lassa fever in Nigeria and the effect on mortality. J Neurol Sci, 333, 2013, e604.
18. Okokhere, PO, Bankole, IA, Iruolagbe, CO, et al. Aseptic meningitis caused by Lassa virus: case series report. Case Rep Neurol Med, 2016, 2016, 4.
19. Okokhere, P, Asogun, D, Okogbenin, SA, The effect of malaria on the outcome of Lassa fever. Int J Infect Dis, 14, 2010, e333.
20. Ibekwe, TS, Okokhere, PO, Asogun, D, et al. Early-onset sensorineural hearing loss in Lassa fever. Eur Arch Otorhinolaryngol 268 (2011), 197–201.
21. Okogbenin, SA, Asogun, D, Akpede, G, Okokhere, P, Gunther, S, Happi, C, New lessons from a case series review of Lassa fever in pregnancy. Int J Infect Dis, 14, 2010, e380.
22. Nathwani, RA, Pais, S, Reynolds, TB, Kaplowitz, N, Serum alanine aminotransferase in skeletal muscle diseases. Hepatology 41 (2005), 380–382.
23. Zapata, B, Fernández-Alemán, J, Idri, A, Toval, A, Empirical studies on usability of mHealth apps: a systematic literature review. J Med Syst 39 (2015), 1–19.
24. Feng, L, Garcia, GE, Yang, Y, et al. Heparin-binding EGF-like growth factor contributes to reduced glomerular filtration rate during glomerulonephritis in rats. J Clin Invest 105 (2000), 341–350.
25. de Geus, HRH, Betjes, MG, Bakker, J, Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clin Kidney J 5 (2012), 102–108.
26. McCullough, PA, Shaw, AD, Haase, M, et al. Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol 182 (2013), 13–29.
27. Koyner, JL, Vaidya, VS, Bennett, MR, et al. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol 5 (2010), 2154–2165.
28. Ehichioya, DU, Hass, M, Becker-Ziaja, B, et al. Current molecular epidemiology of Lassa virus in Nigeria. J Clin Microbiol 49 (2011), 1157–1161.
29. Andersen, KG, Shylakhter, I, Tabrizi, S, Grossman, SR, Happi, CT, Sabeti, PC, Genome-wide scans provide evidence for positive selection of genes implicated in Lassa fever. Philos Trans R Soc Lond B Biol Sci 367 (2012), 868–877.
30. Ajayi, NA, Nwigwe, CG, Azuogu, BN, et al. Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January–March 2012). Int J Infect Dis 17 (2013), e1011–e1116.